Antisense Therapeutics Limited advised the appointment of Ms. Nuket Desem as Director of Clinical and Regulatory affairs. Nuket brings to ANP over 20 years' experience in global regulatory affairs, clinical development and project management obtained through her roles within the pharmaceutical/biotechnology industry, including senior positions in various biotechnology companies. Nuket joins Antisense Therapeutics from Paranta Biosciences, where she held the position of Director Clinical and Regulatory Affairs. There, she led the clinical and regulatory activities associated with the development of Paranta's recombinant human follistatin protein, PB01, for various indications. Prior to Paranta, Nuket was Senior Manager Development and Regulatory Affairs at Prana Biotechnology.